Reuters logo
BRIEF-Acorda announces long-term safety data for CVT-301
2017年3月29日 / 上午10点10分 / 8 个月前

BRIEF-Acorda announces long-term safety data for CVT-301

March 29 (Reuters) - Acorda Therapeutics Inc:

* Acorda announces long-term safety data for cvt-301

* New drug application (NDA) submission planned by end Q2 2017

* Plans to file a marketing authorization application (MAA) in europe by end of 2017

* Pulmonary function measures over 12 months comparable between CVT-301 and observational control group

* Acorda therapeutics - there was one death in study, a drowning in CVT-301 84 MG group, judged by investigator to be not related to study drug Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below